Placeholder

Driving Sales with Data

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 523. Categories: , .

Product Description

VIEW on CERM

Pharmaceutical and device manufacturers are constantly seeking new ways to better communicate the value of their products. Phase IV studies have been the typical means to confirm clinical safety and efficacy, and to understand what happens in “real-world” settings. But, according to F. Randy Vogenberg, Ph.D., senior VP, national practice leader, at Aon Consulting’s Life Sciences Practice, Phase IV research does have limitations…

Sidebar:
Summary Results

Expert on this Topic
F. Randy Vogenberg, Ph.D., Senior VP, National Practice Leader, Aon Consulting’s Life Sciences Practice

FEEDBACK